Pediatric Gastroenterology, Hepatology & Nutrition

The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition (대한소아소화기영양학회)
권호 표지
DOI QR코드

DOI QR Code

Gender Differences in Paediatric Patients of the Swiss Inflammatory Bowel Disease Cohort Study

  • Herzog, Denise (Division of Gastroenterology, Department of Paediatrics, Cantons Hospital of Fribourg) ;
  • Buehr, Patrick (Division of Gastroenterology and Nutrition, University Children's Hospital Zurich) ;
  • Koller, Rebekka (Division of Gastroenterology and Nutrition, University Children's Hospital Zurich) ;
  • Rueger, Vanessa (Division of Gastroenterology and Nutrition, University Children's Hospital Zurich) ;
  • Heyland, Klaas (Division of Gastroenterology and Nutrition, University Children's Hospital Zurich) ;
  • Nydegger, Andreas (Division of Gastroenterology, University Children's Hospital of Lausanne) ;
  • Spalinger, Johannes (Division of Gastroenterology, Children's Hospital of Lucerne) ;
  • Schibli, Susanne (Division of Gastroenterology, University Children's Hospital of Bern) ;
  • Braegger, Christian P. (Division of Gastroenterology and Nutrition, University Children's Hospital Zurich) ;
  • The Swiss IBD Cohort Study Group (The Swiss IBD Cohort Study Group)
  • Received : 2014.05.12
  • Accepted : 2014.08.19
  • Published : 2014.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Gender differences in paediatric patients with inflammatory bowel disease (IBD) are frequently reported as a secondary outcome and the results are divergent. To assess gender differences by analysing data collected within the Swiss IBD cohort study database since 2008, related to children with IBD, using the Montreal classification for a systematic approach. Methods: Data on gender, age, anthropometrics, disease location at diagnosis, disease behaviour, and therapy of 196 patients, 105 with Crohn's disease (CD) and 91 with ulcerative or indeterminate colitis (UC/IC) were retrieved and analysed. Results: The crude gender ratio (male : female) of patients with CD diagnosed at <10 years of age was 2.57, the adjusted ratio was 2.42, and in patients with UC/IC it was 0.68 and 0.64 respectively. The non-adjusted gender ratio of patients diagnosed at ${\geq}10$ years was 1.58 for CD and 0.88 for UC/IC. Boys with UC/IC diagnosed <10 years of age had a longer diagnostic delay, and in girls diagnosed with UC/IC >10 years a more important use of azathioprine was observed. No other gender difference was found after analysis of age, disease location and behaviour at diagnosis, duration of disease, familial occurrence of IBD, prevalence of extra-intestinal manifestations, complications, and requirement for surgery. Conclusion: CD in children <10 years affects predominantly boys with a sex ratio of 2.57; the impact of sex-hormones on the development of CD in pre-pubertal male patients should be investigated.

Keywords

References

  1. Auvin S, Molinie F, Gower-Rousseau C, Brazier F, Merle V, Grandbastien B, et al. Incidence, clinical presentation and location at diagnosis of pediatric inflammatory bowel disease: a prospective population-based study in northern France (1988-1999). J Pediatr Gastroenterol Nutr 2005;41:49-55. https://doi.org/10.1097/01.MPG.0000162479.74277.86
  2. Kugathasan S, Judd RH, Hoffmann RG, Heikenen J, Telega G, Khan F, et al; Wisconsin Pediatric Inflammatory Bowel Disease Alliance. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr 2003;143:525-31. https://doi.org/10.1067/S0022-3476(03)00444-X
  3. Bernstein CN, Blanchard JF, Rawsthorne P, Wajda A. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol 1999;149:916-24. https://doi.org/10.1093/oxfordjournals.aje.a009735
  4. Mamula P, Markowitz JE, Baldassano RN. Inflammatory bowel disease in early childhood and adolescence: special considerations. Gastroenterol Clin North Am 2003;32:967-95. https://doi.org/10.1016/S0889-8553(03)00046-3
  5. Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011;140:1785-94. https://doi.org/10.1053/j.gastro.2011.01.055
  6. Gupta N, Bostrom AG, Kirschner BS, Ferry GD, Winter HS, Baldassano RN, et al. Gender differences in presentation and course of disease in pediatric patients with Crohn disease. Pediatrics 2007;120:e1418-25. https://doi.org/10.1542/peds.2007-0905
  7. Gupta N, Cohen SA, Bostrom AG, Kirschner BS, Baldassano RN, Winter HS, et al. Risk factors for initial surgery in pediatric patients with Crohn's disease. Gastroenterology 2006;130:1069-77. https://doi.org/10.1053/j.gastro.2006.02.003
  8. Thayu M, Shults J, Burnham JM, Zemel BS, Baldassano RN, Leonard MB. Gender differences in body composition deficits at diagnosis in children and adolescents with Crohn's disease. Inflamm Bowel Dis 2007;13:1121-8. https://doi.org/10.1002/ibd.20149
  9. Vasseur F, Gower-Rousseau C, Vernier-Massouille G, Dupas JL, Merle V, Merlin B, et al. Nutritional status and growth in pediatric Crohn's disease: a population-based study. Am J Gastroenterol 2010;105:1893-900. https://doi.org/10.1038/ajg.2010.20
  10. Griffiths AM, Nguyen P, Smith C, MacMillan JH, Sherman PM. Growth and clinical course of children with Crohn's disease. Gut 1993;34:939-43. https://doi.org/10.1136/gut.34.7.939
  11. Sentongo TA, Semeao EJ, Piccoli DA, Stallings VA, Zemel BS. Growth, body composition, and nutritional status in children and adolescents with Crohn's disease. J Pediatr Gastroenterol Nutr 2000;31:33-40. https://doi.org/10.1097/00005176-200007000-00009
  12. Pittet V, Juillerat P, Mottet C, Felley C, Ballabeni P, Burnand B, et al; Swiss IBD Cohort Study Group. Cohort profile: the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS). Int J Epidemiol 2009;38:922-31. https://doi.org/10.1093/ije/dyn180
  13. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989;170:2-6.
  14. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005;19(Suppl A):5A-36A.
  15. Levine A, Griffiths A, Markowitz J, Wilson DC, Turner D, Russell RK, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011;17:1314-21. https://doi.org/10.1002/ibd.21493
  16. CDC growth charts [Internet]. Atlanta (GA): Centers for Disease Control and Prevention [cited 2014 May 11]. Available from: http://www.cdc.gov/growthcharts.
  17. Finkelstein DM. A proportional hazards model for interval-censored failure time data. Biometrics 1986;42:845-54. https://doi.org/10.2307/2530698
  18. Lee GJ, Kappelman MD, Boyle B, Colletti RB, King E, Pratt JM, et al. Role of sex in the treatment and clinical outcomes of pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2012;55:701-6. https://doi.org/10.1097/MPG.0b013e318266241b
  19. Muller KE, Lakatos PL, Arato A, Kovacs JB, Varkonyi A, Szucs D, et al; Hungarian IBD Registry Group (HUPIR). Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2013;57:576-82. https://doi.org/10.1097/MPG.0b013e31829f7d8c
  20. Van Limbergen J, Russell RK, Drummond HE, Aldhous MC, Round NK, Nimmo ER, et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 2008;135:1114-22. https://doi.org/10.1053/j.gastro.2008.06.081
  21. Martin-de-Carpi J, Rodriguez A, Ramos E, Jimenez S, Martinez-Gomez MJ, Medina E, et al; SPIRIT-IBD Working Group of SEGHNP (Sociedad Espanola de Gastroenterologia Hepatologia Nutricion Pediatrica). The complete picture of changing pediatric inflammatory bowel disease incidence in Spain in 25 years (1985-2009): the EXPERIENCE registry. J Crohns Colitis 2014;8:763-9. https://doi.org/10.1016/j.crohns.2014.01.005
  22. Henderson P, Hansen R, Cameron FL, Gerasimidis K, Rogers P, Bisset WM, et al. Rising incidence of pediatric inflammatory bowel disease in Scotland. Inflamm Bowel Dis 2012;18:999-1005. https://doi.org/10.1002/ibd.21797
  23. Griffiths AM. Specificities of inflammatory bowel disease in childhood. Best Pract Res Clin Gastroenterol 2004;18:509-23.
  24. Sawczenko A, Sandhu BK, Logan RF, Jenkins H, Taylor CJ, Mian S, et al. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet 2001;357:1093-4. https://doi.org/10.1016/S0140-6736(00)04309-9
  25. Ishige T, Tomomasa T, Takebayashi T, Asakura K, Watanabe M, Suzuki T, et al. Inflammatory bowel disease in children: epidemiological analysis of the nationwide IBD registry in Japan. J Gastroenterol 2010;45:911-7. https://doi.org/10.1007/s00535-010-0223-7
  26. Wagtmans MJ, Verspaget HW, Lamers CB, van Hogezand RA. Gender-related differences in the clinical course of Crohn's disease. Am J Gastroenterol 2001;96:1541-6. https://doi.org/10.1111/j.1572-0241.2001.03755.x
  27. Montgomery SM, Wakefield AJ, Ekbom A. Sex-specific risks for pediatric onset among patients with Crohn's disease. Clin Gastroenterol Hepatol 2003;1:303-9. https://doi.org/10.1016/S1542-3565(03)00135-6
  28. Cornish JA, Tan E, Simillis C, Clark SK, Teare J, Tekkis PP. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am J Gastroenterol 2008;103:2394-400. https://doi.org/10.1111/j.1572-0241.2008.02064.x
  29. Biank V, Friedrichs F, Babusukumar U, Wang T, Stoll M, Broeckel U, et al. DLG5 R30Q variant is a female-specific protective factor in pediatric onset Crohn's disease. Am J Gastroenterol 2007;102:391-8. https://doi.org/10.1111/j.1572-0241.2006.01011.x
  30. Sagiv-Friedgut K, Karban A, Weiss B, Shaoul R, Shamir R, Bujanover Y, et al. Early-onset Crohn disease is associated with male sex and a polymorphism in the IL-6 promoter. J Pediatr Gastroenterol Nutr 2010;50:22-6. https://doi.org/10.1097/MPG.0b013e3181b7a6a4
  31. Chighizola C, Meroni PL. The role of environmental estrogens and autoimmunity. Autoimmun Rev 2012;11:A493-501. https://doi.org/10.1016/j.autrev.2011.11.027
  32. Markle JG, Frank DN, Mortin-Toth S, Robertson CE, Feazel LM, Rolle-Kampczyk U, et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 2013;339:1084-8. https://doi.org/10.1126/science.1233521
  33. Markle JG, Fish EN. SeXX matters in immunity. Trends Immunol 2014;35:97-104. https://doi.org/10.1016/j.it.2013.10.006
  34. Ventham NT, Kennedy NA, Nimmo ER, Satsangi J. Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics. Gastroenterology 2013;145:293-308. https://doi.org/10.1053/j.gastro.2013.05.050
  35. Pfefferkorn M, Burke G, Griffiths A, Markowitz J, Rosh J, Mack D, et al. Growth abnormalities persist in newly diagnosed children with crohn disease despite current treatment paradigms. J Pediatr Gastroenterol Nutr 2009;48:168-74. https://doi.org/10.1097/MPG.0b013e318175ca7f
  36. Ponsonby AL, Catto-Smith AG, Pezic A, Dupuis S, Halliday J, Cameron D, et al. Association between early-life factors and risk of child-onset Crohn's disease among Victorian children born 1983-1998: a birth cohort study. Inflamm Bowel Dis 2009;15:858-66. https://doi.org/10.1002/ibd.20842

Cited by

  1. Growth and the Growth Hormone-Insulin Like Growth Factor 1 Axis in Children With Chronic Inflammation: Current Evidence, Gaps in Knowledge, and Future Directions vol.37, pp.1, 2014, https://doi.org/10.1210/er.2015-1026
  2. Sex-Related Differences in Patients With Inflammatory Bowel Disease: Results of 2 Prospective Cohort Studies vol.24, pp.6, 2014, https://doi.org/10.1093/ibd/izy004
  3. Gender Difference and Dietary Supplemental Vitamin B6: Impact on Colon Luminal Environment vol.64, pp.2, 2014, https://doi.org/10.3177/jnsv.64.116
  4. Developmental origin and sex-specific risk for infections and immune diseases later in life vol.41, pp.2, 2019, https://doi.org/10.1007/s00281-018-0713-x
  5. MiR-155-Mediated Deregulation of GPER1 Plays an Important Role in the Gender Differences Related to Inflammatory Bowel Disease vol.2020, pp.None, 2014, https://doi.org/10.1155/2020/8811477